Sagar Lonial Introduces Blood Cancers Today

Sagar Lonial, MD, FACP, Talks Multiple Myeloma Highlights from the Summer ConferencesПодробнее

A Look at the CAR-T Pipeline: ddBCMA and LUMMICARПодробнее

Dr. Sagar Lonial on Understanding Multiple MyelomaПодробнее

Which Patients Are Not Well Suited for CAR-T Therapy?Подробнее

Sagar Lonial, MD, FACP, Discusses CAR-T Therapies for MyelomaПодробнее

Sagar Lonial, MD, FACP, on Multiple Myeloma Awareness MonthПодробнее

The HemOnc Pulse Live at ASH: Sagar Lonial, MD, FACP, on Role of Transplant, MRD in MyelomaПодробнее

Myeloma Treatment Selection: CAR-T Versus Bispecific T-Cell Engagers, Bridging Therapy OptionsПодробнее

Myeloma Panel Compares Real-World Versus Clinical Trial Data for CAR-Ts, BispecificsПодробнее

Sagar Lonial, MD on elotuzumab for mutliple myeloma patientsПодробнее

Myeloma Panel Discusses the Latest CAR-T Treatment DataПодробнее

Blood cancers make up about 10% of all new cancer diagnosisПодробнее

IMS Highlights for Triple Class Refractory Myeloma | Sagar Lonial, MD, FACP | IMS 2023Подробнее

Why Winship? - Sagar Lonial, MDПодробнее

Myeloma Crowd Radio: Sagar Lonial, MD, Winship Cancer InstituteПодробнее

Dr. Berenson on the Myeloma BioBank LaunchПодробнее

The Leukemia & Lymphoma Society Roundtable - Innovation in Research: Blood Cancers and BeyondПодробнее